Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in obese children and adolescents with insulin resistance
2004-003816-47Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in insulin resistance (IR), cardiometabolic risk (CMR) and childhood obesity, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change in insulin resistance (HOMA) at 6 months. Started Oct 2005; status: completed.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)cardiometabolic risk (CMR)childhood obesity
Beyond the preview
Go deeper on 2004-003816-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003816-47.